How the pharmaceutical industry may develop a partnership with all health care constituencies to improve the business of health care.

1. Social Media and Pharma: Support for patients, or new commercial channel to care? Rob Halkes October 7, 2010 value innovation in medical and life sciences

5. What is this with Social Media? Crossweb.nl chainconnection.com

6. And What could you do with them? bartvandecasteel.wordpress.com Livecast Virtual Worlds Life stream Social Games MMO Publish Share Discuss Micro blog Social Networks

7. Social Media is about “sharing”

9. Relationship between Content - Privacy 1. 2. 3. 4. General Information Specific Information Private Communication Public Communication The patient’s health care process 4.

11. My colleagues from Deloitte: “ Social networks hold considerable potential value for health care organizations because they can be used to reach stakeholders, aggregate information and leverage collaboration.”

13. Examples of any will take to much time

21. Tremendous Use, e.g. “Mobile Health”

22. And, today:

23. A typical Pharma campaign

24. Living with ADHD, the design:

25. The analysis of communication circles

28. Example: PatientsLikeMe

29. Example: PatientsLikeMe

38. Reconsider, it’s about health outcomes: “ROH”!

40. In pharma: multi-party communities may arise, mingle, interact and promote and warrant participation in the community, not so because it is convenient to pharma, but primarily because the communities create mutual value ! Practice nurses doctors pharmacists specialists Health insurance support Home care support Community agents Pharmaco agents Family and friends Device companies Patients

41. Imagine structuring and solving problems in process of delivery and implementing the therapy Industry HCI GP Ph Nurse Logistics Etc. Family Friends Coach Etc. Patient Other Patients Experience Co Creation in Care, Halkes

43. THANK YOU

45. Van Spaendonck’s BU “Value Innovation in Medical and life Sciences” is a focused consultancy firm. Van Spaendonck management consultancy supports and directs parties and professionals to proper choices and processes to create and develop their USP , a better market position and performance. In the dynamics of health care systems, pharmaceutical industry, health care insurers, social parties, and health care professionals will be challenged more and more to their added value. The business unit “Value innovation for Medical and Life Sciences,” has the needed expertise and experience to initiate and develop processes and clinics for health care, marketing, sales and management systems, professional development, and strategic organisational change. 20 years of consultancy expertise to pharmaceutical and medical industry, life sciences and health care. Actual research and publications in health care and marketing developments. Rob Halkes BU Van Spaendonck – Value innovation in Medical and Life Sciences T +31 418 578000 M+31 653 420722 E r.halkes@VanSpaendonck.nl G.E.H. Tutein Noltheniuslaan 7 W www.medicalandpharmamarketing.com 4181AS Waardenburg T www.twitter.com/rohal the Netherlands